Liu Y - Search Results

1

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes.

Chen X, Wang D, Liu J, Qiu J, Zhou J, Ying J, Shi Y, Wang Z, Lou H, Cui J, Zhang J, Liu Y, Zhao F, Pan L, Zhao J, Zhu D, Chen S, Li X, Li X, Zhu L, Shao Y, Shu Y. Chen X, et al. Among authors: liu j, liu y. J Immunother Cancer. 2021 Nov;9(11):e003214. doi: 10.1136/jitc-2021-003214. J Immunother Cancer. 2021. PMID: 34795005 Free PMC article.

2

Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts.

Xu L, Qu X, Zhang Y, Hu X, Yang X, Hou K, Teng Y, Zhang J, Sada K, Liu Y. Xu L, et al. Among authors: liu y. FEBS Lett. 2009 Mar 4;583(5):943-8. doi: 10.1016/j.febslet.2009.02.014. Epub 2009 Feb 15. FEBS Lett. 2009. PMID: 19223002 Free article.

3

Reversal of P-glycoprotein-mediated multi-drug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells.

Zhang Y, Qu X, Hu X, Yang X, Hou K, Teng Y, Zhang J, Sada K, Liu Y. Zhang Y, et al. Among authors: liu y. J Pathol. 2009 Jun;218(2):248-55. doi: 10.1002/path.2533. J Pathol. 2009. PMID: 19274672

4

PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells.

Li D, Qu X, Hou K, Zhang Y, Dong Q, Teng Y, Zhang J, Liu Y. Li D, et al. Among authors: liu y. Anticancer Drugs. 2009 Jan;20(1):59-64. doi: 10.1097/CAD.0b013e3283160fd6. Anticancer Drugs. 2009. PMID: 19343001

5

GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling.

Zhang Y, Qu X, Jing W, Hu X, Yang X, Hou K, Teng Y, Zhang J, Liu Y. Zhang Y, et al. Among authors: liu y. Anticancer Drugs. 2009 Mar;20(3):208-14. doi: 10.1097/CAD.0b013e328322fbaa. Anticancer Drugs. 2009. PMID: 19396019

6

Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.

Li Y, Qu X, Qu J, Zhang Y, Liu J, Teng Y, Hu X, Hou K, Liu Y. Li Y, et al. Among authors: liu j, liu y. Cancer Lett. 2009 Nov 1;284(2):208-15. doi: 10.1016/j.canlet.2009.04.035. Epub 2009 May 19. Cancer Lett. 2009. PMID: 19457607

7

Cbl-b promotes chemotherapy-induced apoptosis in rat basophilic leukemia cells by suppressing PI3K/Akt activation and enhancing MEK/ERK activation.

Qu X, Li Y, Liu J, Xu L, Zhang Y, Hu X, Hou K, Liu Y. Qu X, et al. Among authors: liu j, liu y. Mol Cell Biochem. 2010 Jul;340(1-2):107-14. doi: 10.1007/s11010-010-0407-8. Epub 2010 Feb 24. Mol Cell Biochem. 2010. PMID: 20177738

8

Initial partial response and stable disease according to RECIST indicate similar survival for chemotherapeutical patients with advanced non-small cell lung cancer.

He L, Teng Y, Jin B, Zhao M, Yu P, Hu X, Zhang J, Li S, Gao Y, Liu Y. He L, et al. Among authors: liu y. BMC Cancer. 2010 Dec 14;10:681. doi: 10.1186/1471-2407-10-681. BMC Cancer. 2010. PMID: 21156055 Free PMC article.

9

Epirubicin enhances TRAIL-induced apoptosis in gastric cancer cells by promoting death receptor clustering in lipid rafts.

Xu L, Qu X, Luo Y, Zhang Y, Liu J, Qu J, Zhang L, Liu Y. Xu L, et al. Among authors: liu j, liu y. Mol Med Rep. 2011 May-Jun;4(3):407-11. doi: 10.3892/mmr.2011.439. Epub 2011 Feb 14. Mol Med Rep. 2011. PMID: 21468584

10

Phosphoinositide 3-kinase/Akt and nuclear factor κB pathways are involved in tumor necrosis factor-related apoptosis-inducing ligand resistance in human gastric cancer cells.

Liu J, Qu X, Xu L, Zhang Y, Qu J, Hou K, Liu Y. Liu J, et al. Among authors: liu y. Mol Med Rep. 2010 May-Jun;3(3):491-6. doi: 10.3892/mmr_00000286. Mol Med Rep. 2010. PMID: 21472268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205,573 results

Search Page

Filters